These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

910 related items for PubMed ID: 30442280

  • 1. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
    Moore A, Young CA, Hughes DA.
    Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
    [Abstract] [Full Text] [Related]

  • 2. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
    Wong CKH, Cheung PWH, Samartzis D, Luk KD, Cheung KMC, Lam CLK, Cheung JPY.
    PLoS One; 2017 Nov; 12(4):e0175847. PubMed ID: 28414745
    [Abstract] [Full Text] [Related]

  • 3. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
    Wei QQ, Hou Y, Chen Y, Ou R, Cao B, Zhang L, Yang T, Shang H.
    Health Qual Life Outcomes; 2021 Jul 20; 19(1):181. PubMed ID: 34284776
    [Abstract] [Full Text] [Related]

  • 4. Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia.
    Meregaglia M, Borsoi L, Cairns J, Tarricone R.
    Eur J Health Econ; 2019 Mar 20; 20(2):181-193. PubMed ID: 28948436
    [Abstract] [Full Text] [Related]

  • 5. Mapping the COPD Assessment Test onto EQ-5D.
    Hoyle CK, Tabberer M, Brooks J.
    Value Health; 2016 Jun 20; 19(4):469-77. PubMed ID: 27325339
    [Abstract] [Full Text] [Related]

  • 6. Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.
    Neilson AR, Jones GT, Macfarlane GJ, Pathan EM, McNamee P.
    Eur J Health Econ; 2022 Nov 20; 23(8):1357-1369. PubMed ID: 35113270
    [Abstract] [Full Text] [Related]

  • 7. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
    Chen G, Garcia-Gordillo MA, Collado-Mateo D, Del Pozo-Cruz B, Adsuar JC, Cordero-Ferrera JM, Abellán-Perpiñán JM, Sánchez-Martínez FI.
    Patient; 2018 Dec 20; 11(6):665-675. PubMed ID: 29876865
    [Abstract] [Full Text] [Related]

  • 8. Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.
    Meunier A, Soare A, Chevrou-Severac H, Myren KJ, Murata T, Longworth L.
    Appl Health Econ Health Policy; 2022 Jan 20; 20(1):119-131. PubMed ID: 34554442
    [Abstract] [Full Text] [Related]

  • 9. Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis.
    Yu L, Yang H, Lu L, Fang Y, Zhang X, Li S, Li C.
    Health Qual Life Outcomes; 2024 Aug 07; 22(1):61. PubMed ID: 39113080
    [Abstract] [Full Text] [Related]

  • 10. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ, Thompson AJ, Turner AJ, Longworth L, McElhone K, Griffiths CEM, Payne K, BADBIR Study Group.
    Value Health; 2018 Aug 07; 21(8):1010-1018. PubMed ID: 30098665
    [Abstract] [Full Text] [Related]

  • 11. Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores.
    Gu NY, Bell C, Botteman MF, Ji X, Carter JA, van Hout B.
    Patient; 2012 Aug 07; 5(3):185-97. PubMed ID: 22765255
    [Abstract] [Full Text] [Related]

  • 12. Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People's Quality of Life Brief Questionnaire (OPQoL-Brief) Scores.
    Kaambwa B, Ratcliffe J.
    Patient; 2018 Feb 07; 11(1):39-54. PubMed ID: 28623629
    [Abstract] [Full Text] [Related]

  • 13. A mapping study in mainland China: predicting EQ-5D-5L utility scores from the psoriasis disability index.
    Su J, Liu T, Li S, Zhao Y, Kuang Y.
    J Med Econ; 2020 Jul 07; 23(7):737-743. PubMed ID: 32223358
    [Abstract] [Full Text] [Related]

  • 14. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
    Lamu AN, Olsen JA.
    Qual Life Res; 2018 Nov 07; 27(11):2823-2839. PubMed ID: 30173314
    [Abstract] [Full Text] [Related]

  • 15. Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study.
    Jiang L, Zhou H, Yang Q, Luo X, Huang D.
    Qual Life Res; 2024 Mar 07; 33(3):805-816. PubMed ID: 38148367
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a crosswalk between the European Quality of Life Five Dimension Five Level and the Menopause-Specific Quality of Life questionnaire.
    Coon C, Bushmakin A, Tatlock S, Williamson N, Moffatt M, Arbuckle R, Abraham L.
    Climacteric; 2018 Dec 07; 21(6):566-573. PubMed ID: 30295111
    [Abstract] [Full Text] [Related]

  • 17. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A, Green C, Telford C, Zajicek J, Wright D.
    Value Health; 2012 Dec 07; 15(8):1084-91. PubMed ID: 23244811
    [Abstract] [Full Text] [Related]

  • 18. Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores.
    Liu T, Li S, Wang M, Sun Q, Chen G.
    Patient; 2020 Oct 07; 13(5):537-555. PubMed ID: 32382953
    [Abstract] [Full Text] [Related]

  • 19. Direct and Indirect Mapping of Assessment of Quality of Life - 6 Dimensions (AQoL-6D) Onto EQ-5D-5L Utilities Using Data From a Multicenter, Cross-Sectional Study of Malaysians With Chronic Heart Failure.
    Tan YJ, Ong SC.
    Value Health; 2024 Dec 07; 27(12):1762-1770. PubMed ID: 39127252
    [Abstract] [Full Text] [Related]

  • 20. Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia.
    Abdin E, Chong SA, Seow E, Verma S, Tan KB, Subramaniam M.
    Qual Life Res; 2019 Jan 07; 28(1):177-186. PubMed ID: 30382480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.